Who owns ARTIVA BIOTHERAPEUTICS INC?
- Ticker: ARTV
- CUSIP Number: 04317a107
Tip: Access positions for across all investors
Analyze quarterly positions in Artiva Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Artiva Biotherapeutics stock
Who bought or sold ARTIVA BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 18M | $174M | 82% | Jun 2026 |
|
| Viking Global Investors | 2.6M | $25M | 100% | Jun 2026 |
|
| Blackstone Group | 2.4M | $23M | 100% | Jun 2026 |
|
| 5AM Venture Management | 2.4M | $23M | 0% | Jun 2026 |
|
| VR Adviser | 2.0M | $20M | 27% | Jun 2026 |
|
| Franklin Resources | 2.0M | $19M | 284% | Jun 2026 |
|
| Caligan Partners | 1.7M | $17M | 100% | Jun 2026 |
|
| Vanguard Capital Management | 982k | $9.5M | 373% | Jun 2026 |
|
| Samsara BioCapital | 955k | $9.3M | 100% | Jun 2026 |
|
| Blue Owl Capital Holdings | 875k | $8.5M | 100% | Jun 2026 |
|
| Propel Bio Management | 696k | $6.8M | 376% | Jun 2026 |
|
| BlackRock | 695k | $6.7M | 226% | Jun 2026 |
|
| Citadel Advisors | 609k | $5.9M | 3740% | Jun 2026 |
|
| Silverarc Capital Management | 525k | $5.1M | 100% | Jun 2026 |
|
| Geode Capital Management | 354k | $3.4M | 248% | Jun 2026 |
|
| Boothbay Fund Management | 314k | $3.0M | 100% | Jun 2026 |
|
| Nantahala Capital Management | 300k | $2.9M | 100% | Jun 2026 |
|
| Revelation Capital Management | 299k | $2.9M | 0% | Jun 2026 |
|
| Alyeska Investment Group | 274k | $2.7M | 174% | Jun 2026 |
|
| Longwood Capital Partners | 260k | $2.5M | 100% | Jun 2026 |
|
| KVP Capital Advisors | 200k | $1.9M | 100% | Jun 2026 |
|
| Wellington Management Company | 194k | $1.9M | 0% | Jun 2026 |
|
| UBS Group | 184k | $1.8M | 11951% | Jun 2026 |
|
| Seven Grand Managers | 175k | $1.7M | 100% | Jun 2026 |
|
| Renaissance Technologies | 151k | $1.5M | 89% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 148k | $1.4M | 352% | Jun 2026 |
|
| ADAR1 Capital Management | 119k | $1.2M | 100% | Jun 2026 |
|
| Simplify Asset Management | 101k | $983k | 336% | Jun 2026 |
|
| Bridgeway Capital Management | 85k | $825k | 143% | Jun 2026 |
|
| Two Sigma Investments | 79k | $762k | -32% | Jun 2026 |
|
| Northern Trust | 76k | $741k | 526% | Jun 2026 |
|
| DAFNA Capital Management | 67k | $651k | 100% | Jun 2026 |
|
| Quadrature Capital | 49k | $479k | 100% | Jun 2026 |
|
| Dimensional Fund Advisors | 45k | $435k | 120% | Jun 2026 |
|
| XTX Topco | 43k | $412k | 110% | Jun 2026 |
|
| State Street Corporation | 36k | $231k | 0% | Mar 2026 |
|
| Vanguard Portfolio Management | 31k | $302k | 100% | Jun 2026 |
|
| Velan Capital Investment Management | 25k | $243k | 0% | Jun 2026 |
|
| Acadian Asset Management | 23k | $221k | 100% | Jun 2026 |
|
| Atom Investors | 23k | $222k | 100% | Jun 2026 |
|
| Bailard | 21k | $201k | 0% | Jun 2026 |
|
| Spark Investment Management | 17k | $160k | 100% | Jun 2026 |
|
| Morgan Stanley | 16k | $106k | -40% | Mar 2026 |
|
| Goldman Sachs Group | 16k | $153k | 38% | Jun 2026 |
|
| Squarepoint Ops | 15k | $144k | 100% | Jun 2026 |
|
| Alliancebernstein | 14k | $136k | 100% | Jun 2026 |
|
| Vanguard Global Advisers | 12k | $116k | 100% | Jun 2026 |
|
| Charles Schwab Investment Management | 12k | $115k | 100% | Jun 2026 |
|
| Sixth Street Partners Management Company | 12k | $115k | 100% | Jun 2026 |
|
| New York State Common Retirement Fund | 6.1k | $59k | 100% | Jun 2026 |
|
| Russell Investments | 5.9k | $57k | 7% | Jun 2026 |
|
| Wells Fargo & Company | 5.5k | $53k | 265% | Jun 2026 |
|
| State of Wyoming | 4.6k | $45k | 100% | Jun 2026 |
|
| Jpmorgan Chase & Co | 4.2k | $40k | 100% | Jun 2026 |
|
| FMR | 3.6k | $35k | 1% | Jun 2026 |
|
| Barclays | 3.3k | $32k | 100% | Jun 2026 |
|
| Royal Bank of Canada | 3.1k | $27k | 1531% | Jun 2026 |
|
| Rhumbline Advisers | 3.0k | $30k | 100% | Jun 2026 |
|
| Mirae Asset Global Etfs Holdings | 2.1k | $21k | 100% | Jun 2026 |
|
| Federation des caisses Desjardins du Quebec | 2.0k | $19k | 100% | Jun 2026 |
|
| China Universal Asset Management | 1.6k | $16k | 100% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 1.1k | $11k | 112% | Jun 2026 |
|
| Legal & General Group | 566.00 | $5.5k | 100% | Jun 2026 |
|
| Steward Partners Investment Advisory | 500.00 | $4.9k | 100% | Jun 2026 |
|
| Summit Investment Advisors | 421.00 | $4.1k | 100% | Jun 2026 |
|
| Mark Sheptoff Financial Planning | 400.00 | $3.9k | 0% | Jun 2026 |
|
| Tower Research Capital | 247.00 | $2.4k | 100% | Jun 2026 |
|
| Us Bancorp | 235.00 | $2.3k | 100% | Jun 2026 |
|
| Mercer Global Advisors | 200.00 | $1.9k | 100% | Jun 2026 |
|
| Quarry | 94.00 | $911.997400 | 100% | Jun 2026 |
|
| Sterling Capital Management | 72.00 | $697.996800 | 100% | Jun 2026 |
|
| Caitong International Asset Management | 13.00 | $125.999900 | 100% | Jun 2026 |
|
| Jones Financial Companies, L.L | 11.00 | $106.000400 | 100% | Jun 2026 |
|
Who sold out of Artiva Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| venBio Partners | Mar 2026 | 531k | $3.4M |
| Millennium Management | Mar 2026 | 123k | $794k |
| Jane Street | Mar 2026 | 40k | $254k |
| PanAgora Asset Management | Mar 2026 | 31k | $198k |
| Sanctuary Advisors | Mar 2026 | 22k | $139k |
| OMERS Administration Corporation | Mar 2026 | 11k | $73k |
| Advisor Group Holdings | Mar 2026 | 18.00 | $115.999200 |